These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 2816898)

  • 1. Re: "Familial ovarian cancer: a population-based case-control study".
    Harlow BL; Weiss NS
    Am J Epidemiol; 1989 Nov; 130(5):1071-3. PubMed ID: 2816898
    [No Abstract]   [Full Text] [Related]  

  • 2. Age at onset for familial epithelial ovarian cancer.
    Amos CI; Shaw GL; Tucker MA; Hartge P
    JAMA; 1992 Oct; 268(14):1896-9. PubMed ID: 1404714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coffee, tea, colas, and risk of epithelial ovarian cancer.
    Song YJ; Kristal AR; Wicklund KG; Cushing-Haugen KL; Rossing MA
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):712-6. PubMed ID: 18349292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of self-reported family history of cancer in a large case-control study of ovarian cancer.
    Soegaard M; Jensen A; Frederiksen K; Høgdall E; Høgdall C; Blaakaer J; Kjaer SK
    Cancer Causes Control; 2008 Jun; 19(5):469-79. PubMed ID: 18197461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproductive risk factors for mucinous and non-mucinous epithelial ovarian cancer.
    Wittenberg J; Cook LS; Rossing MA; Weiss NS
    Epidemiology; 1999 Nov; 10(6):761-3. PubMed ID: 10535792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP17 genotype and ovarian cancer: a null case-control study.
    Goodman MT; McDuffie K; Guo C; Terada K; Donlon TA
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):563-4. PubMed ID: 11352870
    [No Abstract]   [Full Text] [Related]  

  • 7. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
    Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K
    Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina.
    Lancaster JM; Wenham RM; Halabi S; Calingaert B; Marks JR; Moorman PG; Bentley RC; Berchuck A; Schildkraut JM
    Cancer Epidemiol Biomarkers Prev; 2003 Mar; 12(3):226-7. PubMed ID: 12646513
    [No Abstract]   [Full Text] [Related]  

  • 9. [Familial ovarian cancer].
    Ben David Y; Shalev E
    Harefuah; 1997 Jun; 132(12):858-61. PubMed ID: 9264194
    [No Abstract]   [Full Text] [Related]  

  • 10. Analgesic drug use and risk of epithelial ovarian cancer.
    Hannibal CG; Rossing MA; Wicklund KG; Cushing-Haugen KL
    Am J Epidemiol; 2008 Jun; 167(12):1430-7. PubMed ID: 18390840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic epidemiology study of ovarian cancer. I. A comparison of familial and population frequencies].
    Chudina AP; Akulenko LV
    Genetika; 1984 May; 20(5):849-56. PubMed ID: 6539727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated microRNA and mRNA signatures in peripheral blood lymphocytes of familial epithelial ovarian cancer.
    Dou YD; Huang T; Wang Q; Shu X; Zhao SG; Li L; Liu T; Lu G; Chan WY; Liu HB
    Biochem Biophys Res Commun; 2018 Jan; 496(1):191-198. PubMed ID: 29307835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cigarette smoking and risk of epithelial ovarian cancer.
    Rossing MA; Cushing-Haugen KL; Wicklund KG; Weiss NS
    Cancer Causes Control; 2008 May; 19(4):413-20. PubMed ID: 18080774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Integrin beta3 Leu33Pro homozygosity and risk of cancer.
    Wang-Gohrke S; Chang-Claude J
    J Natl Cancer Inst; 2005 May; 97(10):778-9; author reply 779-80. PubMed ID: 15900047
    [No Abstract]   [Full Text] [Related]  

  • 15. [Familial ovarian cancer syndrome].
    Bösze P
    Orv Hetil; 1994 Feb; 135(9):459-64. PubMed ID: 8139849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased risk of ovarian cancer in integrin beta3 Leu33Pro homozygotes.
    Bojesen SE; Kjaer SK; Høgdall EV; Thomsen BL; Høgdall CK; Blaakaer J; Tybjaerg-Hansen A; Nordestgaard BG
    Endocr Relat Cancer; 2005 Dec; 12(4):945-52. PubMed ID: 16322334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk for familial ovarian cancer among Jewish women: a population-based case-control study.
    Steinberg KK; Pernarelli JM; Marcus M; Khoury MJ; Schildkraut JM; Marchbanks PA
    Genet Epidemiol; 1998; 15(1):51-9. PubMed ID: 9523210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care use and risk of ovarian cancer: is there a link?
    Fung-Kee-Fung M; Brouwers M; Oliver TK; Rosen B
    CMAJ; 2007 Mar; 176(7):949-50. PubMed ID: 17389443
    [No Abstract]   [Full Text] [Related]  

  • 19. [A new statistical method on familial correlation dealing with family data from case-control studies].
    Gao YH; Jiang QW; Zhou XF; Ding BG; Wang RH; Zhao GM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Nov; 25(11):992-6. PubMed ID: 15769338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian cancer risk in relation to medical visits, pelvic examinations and type of health care provider.
    Abenhaim HA; Titus-Ernstoff L; Cramer DW
    CMAJ; 2007 Mar; 176(7):941-7. PubMed ID: 17389442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.